DalsnaFinance › IPOs › Moderna › IPO
Moderna, Inc. completed its initial public offering on NASDAQ on December 7, 2018, pricing at $23.00 a share.
| Ticker | MRNA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 7, 2018 |
| Offering price | $23.00 |
| Shares offered | 26,275,993 |
| Total raised | $604M |
Moderna, Inc. sold 26,275,993 shares at $23.00 each on NASDAQ. Multiplied out, that is $604.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $604 million total recorded for the deal.
Moderna, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Moderna, Inc.. This page is general information, not investment advice.